Efficacy and safety of hydrolyzed rice-protein ...
Type de document :
Article dans une revue scientifique: Article original
PMID :
URL permanente :
Titre :
Efficacy and safety of hydrolyzed rice-protein formulas for the treatment of cow''s milk protein allergy.
Auteur(s) :
Bocquet, A [Auteur]
Université de Franche-Comté [UFC]
Dupont, C [Auteur]
Université Paris Descartes - Paris 5 [UPD5]
Chouraqui, Jean-Pierre [Auteur]
Darmaun, D [Auteur]
Université de Nantes [UN]
Feillet, F [Auteur]
Université de Lorraine [UL]
Frelut, M-L [Auteur]
Girardet, J-P [Auteur]
Université Pierre et Marie Curie - Paris 6 [UPMC]
Hankard, R [Auteur]
Niche, Nutrition, Cancer et métabolisme oxydatif [N2Cox]
Université de Tours [UT]
Lapillonne, A [Auteur]
Université Paris Descartes - Paris 5 [UPD5]
Roze, J-C [Auteur]
Université de Nantes [UN]
Simeoni, Umberto [Auteur]
Université de Lausanne = University of Lausanne [UNIL]
Turck, Turck [Auteur]
Lille Inflammation Research International Center - U 995 [LIRIC]
Briend, A [Auteur]
Institut de Recherche pour le Développement [IRD]
Université de Franche-Comté [UFC]
Dupont, C [Auteur]
Université Paris Descartes - Paris 5 [UPD5]
Chouraqui, Jean-Pierre [Auteur]
Darmaun, D [Auteur]
Université de Nantes [UN]
Feillet, F [Auteur]
Université de Lorraine [UL]
Frelut, M-L [Auteur]
Girardet, J-P [Auteur]
Université Pierre et Marie Curie - Paris 6 [UPMC]
Hankard, R [Auteur]
Niche, Nutrition, Cancer et métabolisme oxydatif [N2Cox]
Université de Tours [UT]
Lapillonne, A [Auteur]
Université Paris Descartes - Paris 5 [UPD5]
Roze, J-C [Auteur]
Université de Nantes [UN]
Simeoni, Umberto [Auteur]
Université de Lausanne = University of Lausanne [UNIL]
Turck, Turck [Auteur]
Lille Inflammation Research International Center - U 995 [LIRIC]
Briend, A [Auteur]
Institut de Recherche pour le Développement [IRD]
Titre de la revue :
Archives de Pédiatrie
Nom court de la revue :
Arch Pediatr
Numéro :
26
Pagination :
238-246
Date de publication :
2019-05
ISSN :
1769-664X
Discipline(s) HAL :
Sciences du Vivant [q-bio]
Résumé en anglais : [en]
Foods for special medical purposes (FSMPs) with a protein fraction made of hydrolyzed rice protein (HRPs) have been on the market in Europe since the 2000s for the treatment of cow's milk protein allergy (CMPA). HRP formulas ...
Lire la suite >Foods for special medical purposes (FSMPs) with a protein fraction made of hydrolyzed rice protein (HRPs) have been on the market in Europe since the 2000s for the treatment of cow's milk protein allergy (CMPA). HRP formulas (HRPFs) are proposed as a plant-based alternative to cow's milk protein-based extensively hydrolyzed formulas (CMP-eHF) beside the soy protein formulas whose use in CMPA is controversial. HRPFs do not contain phytoestrogens and are derived from non-genetically modified rice. HRPFs are strictly plant-based apart from the addition of vitamin D (cholecalciferol). As the amino acid content of rice proteins differs from that of human milk proteins, the protein quality of these formulas is improved by supplementation with free lysine, threonine, and tryptophan. The consumption of HRPFs has risen: for example, in France HRPFs account for 4.9% in volume of all formulas for children aged 0-3 years. Several studies have shown the adequacy of HRPFs in treating CMPA. They ensure satisfactory growth from the 1st weeks of life for infants and toddlers, both in healthy children and in those with CMPA. HRPFs can be used to treat children with CMPA either straightaway or in second intention in cases of poor tolerance to CMP-eHF for organoleptic reasons or for lack of efficacy. In France, the cost of HRPFs is close to that of regular infant or follow-on formulas.Lire moins >
Lire la suite >Foods for special medical purposes (FSMPs) with a protein fraction made of hydrolyzed rice protein (HRPs) have been on the market in Europe since the 2000s for the treatment of cow's milk protein allergy (CMPA). HRP formulas (HRPFs) are proposed as a plant-based alternative to cow's milk protein-based extensively hydrolyzed formulas (CMP-eHF) beside the soy protein formulas whose use in CMPA is controversial. HRPFs do not contain phytoestrogens and are derived from non-genetically modified rice. HRPFs are strictly plant-based apart from the addition of vitamin D (cholecalciferol). As the amino acid content of rice proteins differs from that of human milk proteins, the protein quality of these formulas is improved by supplementation with free lysine, threonine, and tryptophan. The consumption of HRPFs has risen: for example, in France HRPFs account for 4.9% in volume of all formulas for children aged 0-3 years. Several studies have shown the adequacy of HRPFs in treating CMPA. They ensure satisfactory growth from the 1st weeks of life for infants and toddlers, both in healthy children and in those with CMPA. HRPFs can be used to treat children with CMPA either straightaway or in second intention in cases of poor tolerance to CMP-eHF for organoleptic reasons or for lack of efficacy. In France, the cost of HRPFs is close to that of regular infant or follow-on formulas.Lire moins >
Langue :
Anglais
Audience :
Internationale
Vulgarisation :
Non
Établissement(s) :
CHU Lille
Inserm
Université de Lille
Inserm
Université de Lille
Date de dépôt :
2019-10-22T07:44:19Z
2023-12-08T15:37:14Z
2023-12-08T15:37:14Z
Fichiers
- document
- Accès libre
- Accéder au document